Survival Rates of Heart Transplant Patients at Cedars-Sinai Medical Center

At Cedars-Sinai Medical Center, one-month, one-year and three-year survival rates are tracked for transplants patients.

The table below compares key outcome measurements for heart transplants done at Cedars-Sinai Medical Center.

Both the numbers and percentages of heart transplant patients surviving one month, one year and three years are highlighted. In addition, survival rates for heart transplant patients at Cedars-Sinai Medical Center are also compared to survival rates expected for heart transplant patients with similar ages and health conditions.

The one-month and one-year survival rates reflect patients receiving their first transplant between Jan. 1, 2006 and June 30, 2008. The three-year survival rate reflects patients receiving their first transplant between July 1, 2003 and Dec. 31, 2005.

Heart Transplant* (Adults Age 18+)	Cedars-Sinai Medical Center
Patient Survival for:	1 Month	1 Year	3 Years
For transplants performed	Jan 2006 - June 2008	Jan 2006 - June 2008	July 2003 - Dec 2005
Number of transplants	77	77	61
Percent of patients surviving at the end of period observed**	98.70%	95.69%	85.25%
Expected, based on national experience***	96.33%	90.36%	83.74%
Cedars-Sinai's survival rates compared to what is expected for similar patients	Not significantly different	Not significantly different	Not significantly different

* These statistics reflect patients age 18 or older who had their first heart transplant. They do not include anyone who had a multiple organ transplant (such as a heart and lung transplant0.

** Observed survival rates use the Kaplan-Meier method to estimate outcomes for patients for whom complete follow-up is not expected. Because different cohorts are followed for each time period, it is possible for the reported three-year survival to exceed one-year survival.

*** The survival rate that would be expected for the patients served by the center, given the characteristic mix of the recipient and donor (age, disease and blood type, etc.) and the experience of similar patients in the United States as a whole.